Home › Amgen seeks FDA approval for monthly dosing option for Repatha
 

Keywords :   


Amgen seeks FDA approval for monthly dosing option for Repatha

2015-09-11 17:48:27| Biotech - Topix.net

Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha. The FDA approved Repatha, one of two approved treatments in a new class of injectable "bad" cholesterol-lowering drugs called PCSK9 inhibitors, on Aug. 27. The drug is approved for patients with hereditary forms of high cholesterol - heterozygous familial hypercholesterolemia and a rarer homozygous form of the condition, in addition to those with cardiovascular disease.

Tags: option monthly approval seeks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Hurricane Beryl Forecast Discussion Number 23
04.07Hurricane Beryl Public Advisory Number 23
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 23
04.07Hurricane Beryl Forecast Advisory Number 23
04.07Atlantic Tropical Weather Outlook
04.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
More »